Search results
Reasons to Hold Charles River (CRL) in Your Portfolio Now
Zacks via Yahoo Finance· 1 day agoThe strengthening of the euro and some other developed market currencies has been constantly...
Chinese shopping app Temu faces stricter EU safety rules
AFP via Yahoo News· 5 hours agoChinese shopping app Temu will have to comply with stringent new safety rules after Brussels on...
Charles River Laboratories International (NYSE:CRL) Cut to “Hold” at StockNews.com
ETF DAILY NEWS· 7 days agoEvercore ISI increased their target price on Charles River Laboratories International from $260.00 to $265.00 and gave the stock an “outperform” rating in a report on Thursday ...
EU in touch with Telegram as it nears criterion for EU tech rules
Reuters· 3 days agoThe Digital Services Act (DSA) which kicked in last year applies to all online intermediaries and...
David Beckham signs deal to be brand ambassador for Chinese giant Alibaba
The Independent via Yahoo Finance· 3 days agoIn the January to March quarter this year, the company’s international division (AIDC) saw a 45 per...
Meta, Mark Zuckerberg face shareholder pressure over efforts to protect kids online: Need...
NY Post via Yahoo Finance· 3 days agoZuckerberg faces a potential revolt at Meta's annual meeting on Wednesday as shareholders push the...
As contract expiration nears, Chicago teachers need a strategy to defeat another sellout
World Socialist Web Site· 1 day agoEducators: Take up the fight for rank-and-file control! The Chicago Teachers Union (CTU) began...
Progressive groups squeeze Durbin over judicial ethics
Politico· 2 days ago...Freedmen’s Political Action Committee (Hybrid PAC) Independent (Super PAC) The Lincoln Club of Coachella Valley (PAC) NYC-DSA Federal PAC (PAC) Patriots United for the Republic Inc (PAC) WOMEN UNITED FOR AMERICA (Super PAC) Akin Gump Strauss...
HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated...
WJTV Jackson· 6 days ago82% (n=9/11) of patients on felzartamab experienced resolution of antibody-mediated rejection per Banff criteria on biopsy at 24 weeks versus 20% (n=2/10) who received placebo, and patients ...
